Glycobiology Market To Surpass US$ 2,700.5 Million By 2027 - Coherent Market InsightsGlycobiology Market Report Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
The increasing number of product launches such as mass spectrometry devices, high profile liquid chromatography (HPLC) devices, and others is expected to drive the global glycobiology market growth. For instance, in May 2019, Shimadzu Corporation announced the launch of Novel Shimadzu MALDImini-1 Digital Ion Trap Mass Spectrometer, which provides fast. Global Glycobiology Market– Impact of Coronavirus (COVID-19) Pandemic Supply chain and manufacturing activities in India, Italy, Spain, the U.K., and the U.S. have been disrupted due to lockdowns implemented by various governments in the past few months, while countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drug products. The coronavirus or COVID-19 outbreak that started from Wuhan, China, has spread across continents, affecting various industries globally. Supply of key materials has been severely disrupted due to forced quarantine and lack of labor and raw materials. * The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology. Request a sample copy of this report: https://www.coherentmarketinsights.com/ As the supply link between regional warehouses is not smooth, the transportation of raw materials between various regions cannot be carried out successfully. This shortage of raw materials and components have affected the supply chain of the global glycobiology market. The COVID-19 pandemic has impacted the global economy and in turn, the glycobiology market. Moreover, rise in research and development related to oligosaccharides is also expected to aid in growth of the global glycobiology market over the forecast period. For instance, in February 2020, researchers from University of Kentucky, U.S. reported the use of a high-throughput assay to determine the effect of various post-translational modifications of the Chondroitin sulfate proteoglycansaggrecan upon neurite outgrowth from NS-1 cells. Browse Research Report: https://www.coherentmarketinsights.com/ Key Takeaways of the Global Glycobiology Market: The global glycobiology market is expected to exhibit a CAGR of 12.8% during the forecast period owing to the increasing focus on manufacturing anti-cancer drugs, this is expected to boost growth of the market. Major players operating in the global glycobiology market are Merck & Co., Inc., Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Plexera LLC, New England Biolabs, and Agilent Technologies, Inc. Buy-Now this research report: https://www.coherentmarketinsights.com/ End
|
|
Account Phone Number